NeuroTherapia has concluded its Phase IIa clinical trial of NTRX-07, an orally available molecule, for Alzheimer's disease ...

Radiopharmaceuticals are rapidly becoming one of the most dynamic areas of oncology drug development. By combining molecular targeting with controlled radiation delivery, these therapies introduce a ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the 'Company”), a clinical-stage pharmaceutical company developing targeted ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform ...

The NSF-DOE Vera C. Rubin Observatory has logged more than 11,000 new asteroids from its earliest observations, including 33 ...

Physicists Gimin Bae, Youngjae Kim, and Jae Dong Lee have identified a specific microscopic process that causes quantum ...

Background Transcatheter aortic valve replacement (TAVR) has increasingly emerged as one of the primary treatments for ...

Enphase Energy (ENPH) ended the recent trading session at $33.64, demonstrating a -3.67% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of ...

Researchers have developed a new imaging technique that captures more information about ultrafast processes in the ...

Differentiated Oral Candidate Targeting Soluble Amyloid Oligomer Pathology, with Additional Mechanism of Action as APOE4 CorrectorALZ-507 IND Program Demonstrated Favorable Nonclinical Safety and ...

Near-infrared spectroscopy, or fNIRS, offers a way to monitor brain activity without surgery or radiation by tracking changes in blood flow and oxygenation. Light sources placed on the scalp send near ...

Novel OCTA metrics show conbercept loading injections enhance microvascular perfusion and complexity in proliferative diabetic retinopathy.